Biotech Values

[iwfal]

TOCA

Why do you think the FDA granted TOCA BTD and allowed the Phase II to become a Phase III? What might the FDA be seeing?

Same reasons you like it. I am not being flip, but the bull case is fairly obvious. But the FDA is far from error proof in designating BTD. See https://www.fiercebiotech.com/biotech/breakthroughs-broke-down .

And they seem to be getting progressively more lax.

TOCA has gotten very cheap.

Ok, I'll have to look at it again. If it is cheap enuf, they are efficient at execution and run a good ph3 they might be worth a reload. (Remember that my primary point was that they may have some efficacy, but just unlikely to have the anywhere near the efficacy implied by their PRs).